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Synthesis and secretion of biologically active human lymphotoxin (LT) can be detected in Xenopus Zaevis 
oocytes following their inoculation with poly(A+) RNA from human stimulated peripheral blood lympho- 
cytes, but not in oocytes inoculated with RNA from unstimulated lymphocytes or from fibroblastoid cells. 
In size-fractionating mRNA of stimulated lymphocytes most LT activity is found to be coded for by RNA 
with an approximate s dimentation value of 19 S. 
Lymphotoxin mRNA translation Interferon-y 
1. INTRODUCTION 
Upon stimulation of T cells by agents such as an- 
tigens, lectins or allogeneic cells, these cells secrete 
proteins which can exert cytotoxic effects (review 
[l-3]). Similar proteins are also secreted spon- 
taneously by cells of certain continuous B lym- 
phocyte lines [4,5]. Our knowledge of the 
mechanisms by which these so-called lymphotoxins 
(LTs) are formed is quite limited. There is 
fragmentary information on the effect of various 
regulatory agents on the formation of LTs. Thus, 
interferon (IFN) and certain other lymphokines 
were found to enhance the production of LT in 
cultures of T lymphocytes ([6], unpublished), and 
the tumor-promoting agent phorbol-myristate- 
acetate increases LT secretion by cells of B lym- 
phocyte lines (unpublished), while prostaglandin E 
and corticosteroids have a marked inhibitory effect 
on the production of LT [6,7]. However, there is 
no information on the nature of the intracellular 
events underlying the regulation of LT formation 
by these various agents. To approach the analysis 
of those mechanisms we found it necessary to 
define a technique for detection and quantitation 
Abbreviations: CHI, cycloheximide; IFN, interferon; 
LT, lymphotoxin 
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of the mRNA which codes for LT. We report here 
that mRNA from human peripheral blood lym- 
phocytes, with an approximate sedimentation 
value of 19 S, is translated in microinjected 
Xenopus oocytes to biologically active LT and that 
by this translation technique the level of LT 
mRNA is found to be significantly increased in 
lymphocytes consequently to their stimulation. 
2. MATERIALS AND METHODS 
2.1. Stimulation of lymphocytes 
Human peripheral blood lymphocytes, isolated 
on Ficoll-Hypaque from buffy coats of freshly 
donated blood were used at a concentration of 10’ 
cells/ml in MEM alpha medium (Gibco, NY). 
Prior to stimulation the lymphocytes were in- 
cubated for 12 h in the presence of a lymphokine 
preparation (produced as described below), since 
we recently found that the effectiveness of LT pro- 
duction was dramatically increased by such 
pretreatment (in preparation). Phytohemagglutin- 
in-P (5 pg/ml) (Difco, Detroit) was then added, 
and the lymphocytes were further incubated for 
5 h and then extracted for isolation of their 
mRNA. The lymphokine preparations, applied in 
the preincubation period, were produced by in- 
cubating peripheral blood lymphocytes with con- 
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canavalin A (20 @g/ml; Miles Yeda, Israel) for 
24 h; they were partially purified by adsorption to 
controlled pore glass (PG-350-200, Sigma, St. 
Louis) and desorption in 0.5 M tetramethyl am- 
monium chloride, then subjected to acidification 
to pH 2.0 followed by neutralization and applied 
on lymphocytes at a concentration of 0.2pg/ml. 
2.2. Extraction and purification of RNA 
For extraction of their mRNA, cells (freshly 
isolated lymphocytes, lymphocytes stimulated as 
described above or SV-80 cells) were rinsed twice 
with cold phosphate-buffered saline and then 
solubilized in guanidine thiocyanate and their 
RNA sedimented through a cushion of CsCl solu- 
tion, with minor modifications of a procedure 
described in [S]: the cells were suspended in a solu- 
tion containing 4 M guanidine thiocyanate, 0.1 M 
Tris-Cl (pH 7.4) and 0.1 M P-mercaptoethanol, 
and homogenized with an ‘ultra turrax’ for 10 s. 
CsCl (1 g/2.5 ml) was then added and the 
homogenate was applied on a 5 ml cushion of 
5.7 M CsCl in 0.1 M EDTA (pH 7.5) and spun in 
an SW27 Beckman rotor at 26000 rpm for 20 h. 
The RNA pellet was suspended in a solution con- 
taining 0.1 M sodium acetate and 0.1% SDS, ex- 
tracted consecutively with phenol and chloroform 
and with chloroform alone and was then 
precipitated by adding sodium acetate (pH 5.0) to 
0.2 M and 2.5 vols ethanol. Poly(A+) RNA was 
isolated on oligo(dT)-cellulose columns [8]. 
2.3. Fractionation of poly(A+) RNA by 
electrophoresis through agarose gel in the 
presence of methylmercuric hydroxide and by 
sedimentation through a sucrose gradient 
Fractionation of poly(A+) RNA by elec- 
trophoresis was carried out according to the pro- 
cedure of [9] as described in [8]. Following elec- 
trophoresis, the gel was sliced into 2 mm slices. 
Each slice was crushed with a spatula and suspend- 
ed in 1.0 ml of a solution containing 0.5 M NaCl, 
50 mM Tris-Cl pH 7.4, 5 mM EDTA, 10 mM 
dithiothreitol and 20 pg E. coli tRNA. It was then 
homogenized by passing twice through a 21 gauge 
needle. SDS was added to 0.02070, and the solution 
was extracted, once with phenol and chloroform 
and twice with chloroform alone. The RNA was 
then precipitated by adding sodium acetate (pH 
5.0) to 0.2 M and ethanol to 70%. After rinsing 
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the RNA pellets with 80% ethanol each pellet was 
solubilized in 3 yl water. For fractionation on a 
sucrose gradient a sample of 50 pg poly(A+) RNA 
was denatured by heating for 5 min at 65°C in the 
presence of 0.5% SDS, and then applied on a gra- 
dient of 5-30% (w/v) sucrose in 0.5% SDS, 
10 mM Tris-Cl (pH 7.4) and spun for 9 h at 
40000 rpm in an SW41 Beckman rotor. Fractions 
of 0.4 ml were then collected and following the ad- 
dition of E. coli tRNA (20 pg/fraction) the RNA 
of each fraction was precipitated in sodium acetate 
pH 5.0 and ethanol, rinsed with 80% ethanol and 
solubilized in water as described above. 
2.4. Translation of the RNA in microinjected 
oocytes 
X. laevis oocytes were microinjected in groups 
of 10, each oocyte receiving 10 nl of a solution of 
poly(A+) RNA in distilled water (1 pg/ml) or water 
alone. Each group of oocytes was then incubated 
for 24 h at 22°C in 100 ~1 of Barth’s solution sup- 
plemented with BSA (0.1 mg/ml) and the follow- 
ing protease inhibitors: leupeptin (2 pug/ml), 
pepstatin (4 pg/ml), bacitracin (2 mg/ml), 
aprotinin (0.4 U/ml), and EGTA (2 mg/ml). The 
inclusion of these compounds, for the purpose of 
inhibiting proteolytic enzymes which are released 
by the oocytes [lo], increased significantly the 
yield of LT activity in the oocyte incubation 
medium. Following incubation, the oocytes were 
either homogenized in their incubation media or 
separated from the incubation medium and 
homogenized in a fresh sample of 100~1 Barth’s 
medium. Homogenization was done by crushing 
the oocytes with a small plastic rod and then press- 
ing them several times through a micropipet. The 
oocyte homogenates and the oocyte incubation 
media were diluted 1: 1 with Dulbecco’s modified 
Eagle’s medium, supplemented with 10% fetal calf 
serum, and spun in a microcentrifuge for 2 min at 
10000 rpm. Fat-free fluid was collected from the 
spun samples and assayed immediately for LT and 
IFN activities. Oocytes from different frogs dif- 
fered markedly in the efficiency of translation of 
LT (and of IFN-y) mRNAs. On the other hand, 
the variability of LT yield from one sample of 
oocytes to another, when injecting RNA to oocytes 
of the same frog, was just in the range of 30% of 
the average. Several frogs were therefore screened 
for optimal translational activity, and in each ex- 
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periment oocytes taken from a single frog were 
used. 
2.5. Quantitation of LT and of IFN activities 
LT activity was quantitated as in [ll]. The 
samples tested were diluted serially and applied at 
the various dilutions, in duplicates, to confluent 
cultures of human SV-80 cells [ 121, grown in g-mm 
microwells. Except where otherwise indicated, 
CHI at 50pg/ml was added to the cells 
simultaneously with LT. Following incubation 
with the samples tested, for the indicated period, 
viability of the cells was determined by measuring 
the uptake of neutral red [l 11. The extent of cell 
death is presented as a percentage, comparative to 
the amount of neutral red taken up by cells in- 
cubated with CHI alone. In the absence of LT and 
in the presence of CHI alone, SV-80 cells remain 
viable for at least 24 h. One unit of LT is defined 
as the concentration which, when applied on SV-80 
cells simultaneously with CHI (50 pug/ml), kills 
50% of the cells during 12 h of incubation. 
IFN activity was determined on human WISH 
cells [13] by measuring the reduction in the 
cytopathic effect of vesicular stomatitis virus. One 
unit of IFN activity was defined as the concentra- 
tion of IFN at which 50% of the infected cells were 
protected. Viral cytopathy was quantitated similar- 
ly to the quantitation of LT cytotoxicity by 
measuring the reduction in uptake of neutral red. 
2.6. Materials 
X. Iaevis females were purchased from the South 
African snake farm (Fish Hoek, South Africa). 
Methylmercuric hydroxide (1 M in water) was ob- 
tained from Alfa Division, Ventron (Danvers, 
MA). LT was produced and partially purified as in 
[ 111. Goat antiserum against human lymphokines, 
raised by repeated immunization with crude 
preparations of IFN-y, was a gift from Dr E. 
Falcoff, Institut Curie, Paris, France. One ml of 
that serum could neutralize 350 units LT. 
3. RESULTS AND DISCUSSION 
Cytotoxic activity could be detected in Xenopus 
oocytes 24 h after their inoculation with poly(A+) 
RNA from human, stimulated, peripheral blood 
lymphocytes. As shown in fig.1, cytotoxicity was 
exerted by homogenates of these oocytes as well as 
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Fig. 1. Cytotoxic activity in oocytes injected with mRNA 
of stimulated lymphocytes (0), compared with oocytes 
injected with mRNA of SV-80 cells (0). Each oocyte 
was microinjected with 100 nl containing 100 ng RNA, 
and incubated in groups of 10, for 24 h in 100 pl Barth’s 
solution. Samples of the oocyte incubation media nd of 
homogenates of the oocytes (100 ,ul homogenates 
prepared from each group of 10 oocytes) were serially 
diluted and applied, at the indicated ilution, on SV-80 
cells together with CHI (50 pg/ml). 20 h later the extent 
of cell killing by the samples tested was determined by 
the neutral-red uptake assay. Other details as described 
in section 2. 
by the oocyte-incubation medium, indicating that 
the compounds responsible for that activity were 
partly secreted by the oocytes. Human SV-80 cells 
(f&.1), human HeLa cells, and mouse L929 cells 
(not shown) were similarly vulnerable to the 
cytotoxicity produced in the oocytes. 
The following evidence indicates that the 
cytotoxicity was due to synthesis of human LT, 
coded for by the microinjected RNA: (1) The 
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Table 1 
The cytotoxic activity produced in oocytes injected with lymphocyte RNA can be neutralized by an 
antiserum against human lymphokines and is dependent on sensitization of the target W-80 cells with 
CHI. RNA from unstimulated lymphocytes or from fibroblastoid cells do not code for cytotoxic 
activity 
Expt . Samples injected into oocytes Conditions of assay LT effect 
(070 cells killed) 
CHI Neutralization with an 
antiserum against lymphokines 
1 water + _ <2 
poly(A+) RNA from SV-80 
cells + - <2 
poly(A+) RNA from 
stimulated lymphocytes + - 37 
poly(A+) RNA from + goat antiserum against <2 
stimulated lymphocytes human lymphokines (1: 40) 
poly(A+) RNA from 
stimulated lymphocytes + normal goat serum (1 : 40) 35 
poly(A+) RNA from 
stimulated lymphocytes - - <2 
2 poly(A+) from unstimulated 
lymphocytes + - <2 
poly(A+) from stimulated 
lymphocytes + - 41 
24 h following microinjection, the oocytes were homogenized in their incubation medium and applied, 
at a dilution of 1: 16, on SV-80 cells in the presence or absence of CHI (50 &ml). To neutralize the 
cytotoxic activity with antiserum against lymphokines, the oocyte homogenate was incubated with goat 
antiserum against human lymphokines or, for comparison, with normal goat serum, both at a dilution 
of 1:40, for 1 h at 4°C. The extent of cell killing was determined 20 h following application of the 
oocyte homogenate. Each of the two experiments presented in this table as well as the two presented 
in table 2 were carried out twice with qualitatively the same results 
cytotoxic activity could be fully neutralized by an 
antibody raised against human lymphokine 
preparations (table 1, expt. 1). (2) No cytotoxic ac- 
tivity could be observed in oocytes which had not 
been injected with mRNA (table 1, expt. I), or in 
oocytes injected with mRNA from human 
fibroblastoid cells or from unstimulated lym- 
phocytes (fig.1 and table 1, expts 1 and 2). (3) 
Similar to the cytotoxic effect of lymphocyte- 
produced LT [l 11, the cytotoxic activity produced 
by the microinjected oocytes could be exerted on 
the W-80 cells only when they were sensitized by 
metabolic blockers such as cycloheximide (CHI) 
(table 1, expt.1). (4) In the absence of CHI, LT 
preparations not only failed to kill the SV-80 cells 
but rather induced, in these and in various other 
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cells, resistance to their own cytotoxicity, as 
reflected in decreased vulnerability to a subsequent 
incubation with LT in the presence of CHI [ 111. As 
shown in table 2, lymphocyte-produced LT 
cytotoxicity and the cytotoxicity produced in the 
oocytes behaved identically with respect to the 
characteristics described above: lymphocyte- 
produced LT preparations induced, in the absence 
of CHI, resistance to the cytotoxic activity pro- 
duced by the oocytes (table 2, exptl), and con- 
versely, treating SV-80 cells in the absence of CHI 
with incubation medium of oocytes which had 
been inoculated with lymphocyte RNA (but not of 
oocytes inoculated with RNA from fibroblasts or 
water) decreased their vulnerability to the cyto- 
toxic effect of lymphocyte-produced LT (table 2, 
expt.2). 
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Table 2 
In the absence of CHI, LT preparations, produced by stimulated lymphocytes and by oocytes injected with lymphocyte 
mRNA have mutual protective effects against their cytotoxicity 
Expt. Pretreatment for 4 h in the Treatment for 12 h in the 
absence of CHI presence of CHI 
I II III IV 
Sample applied LT concentration Sample applied LT effect 
in pretreatment (070 cells killed) 
1 Protection against oocyte- - 0 oocyte-produced 
produced cytotoxicity by LT (0.3 U/ml) 24 
lymphocyte-produced LT lymphocyte- oocyte-produced 
produced LT 250 U/ml LT (0.3 U/ml) 3 
2 Protection against lymphocyte- Incubation 
produced LT by oocyte- medium of oocytes 
produced LT preparation which were: 
- microinjected lymphocyte- 
with water 0 produced LT 
(0.45 U/ml) 34 
- microinjected lymphocyte- 
with W-80 RNA 0 produced LT 
(0.45 U/ml) 35 
- microinjected 0.4 U/ml lymphocyte- 
with RNA from produced LT 
stimulated (0.45 U/ml) 18 
lymphocytes 
Confluent cultures of SV-80 cells were incubated for 4 h in the absence of CHI, with the samples indicated in column 
I, then rinsed twice and incubated for 12 h, in the presence of CHI (50pg/ml), with the samples indicated in column 
III. The extent of cell killing by the end of the second incubation, as quantitated by the neutral-red uptake assay is given 
under column IV. ‘Oocyte-produced LT’ was prepared by injecting oocytes with mRNA of stimulated lymphocytes, 
incubating them for 24 h and then homogenizing them in their incubation medium. It was applied on the SV-80 cells 
at a dilution of 1: 16 
To determine the molecular size of the mRNA 
which codes for LT in oocytes, poly(A+) RNA of 
stimulated lymphocytes, denatured with methyl- 
mercuric hydroxide, was fractionated by elec- 
trophoresis through an agarose gel and the RNA 
fractions were assayed for translation to LT in 
microinjected oocytes. To check the resolving 
power of this procedure the fractionation pattern 
of mRNA for another lymphokine: interferon-y 
was determined simultaneously by measuring also 
the production of antiviral activity in the microin- 
jetted oocytes. Consistent with observations of 
others [14-181, we found that the mRNA for IFN- 
y migrated upon electrophoresis as a single species 
and that its sedimentation value was about 16.5 S. 
On the other hand, most mRNA coding for LT 
migrated with an approximate sedimentation value 
of 19 S, which could be calculated to correspond 
to a size of about 2300 nucleotide residues. Very 
low but reproducible cytotoxicity was also ob- 
served in oocytes inoculated with mRNA of about 
17 S (fig.2). A somewhat lower sedimentation 
value for the mRNAs of LT (15 S) and of 1FN-y 
(12 S) were observed in fractionating RNA of 
stimulated lymphocytes by sedimentation through 
a sucrose gradient (as described in section 2). That 
difference between the two fractionation pro- 
cedures may be related to the retainment of some 
secondary structure of the RNAs upon sedimenta- 
tion through sucrose in the absence of an effective 
denaturing agent. 
The presence of mRNA which can code for LTs 
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Fig.2. Electrophoresis of mRNA for LT and IFN-7 
through agarose-methylmercuric hydroxide gel. A 
(5Opg) sample of poly(A+) RNA from stimulated 
human peripheral blood lymphocytes, was mixed with 
radioactive RNA markers (32P-labeled cytoplasmic RNA 
of Vero cells) and subjected to electrophoresis through 
a horizontal slab gel of I.2070 agarose in the presence of 
methylmercuric hydroxide [S,P] until the bromophenol 
blue marker dye migrated 18 cm. The gel was then sliced 
into 2 mm slices which were counted by Cerenkov 
counting to locate the position of the radioactive 
markers (x). The RNA extracted for each of the slices 
(see section 2) was microinjected into oocytes and the 
level of cytotoxic activity in the oocyte homogenates 
(o), as well as cytotoxic activity (0) and IFN (A) in the 
oocyte incubation media were determined at 24 h 
following microinjection as described in section 2. LT 
and IFN levels are expressed in terms of their titer in the 
oocyte incubation media and in the oocyte homogenates. 
in lymphocytes stimulated to produce these pro- 
teins and the absence of such translationally active 
mRNA in nonstimulated lymphocytes (table 1, 
expt.2) indicate that LT formation is regulated at 
the level of gene expression. The oocyte translation 
technique can be a valuable aid in further study of 
this regulation and in cloning the LT genes. It can 
serve as an assay to determine the extent of enrich- 
ment of LT mRNA in RNA preparations used for 
construction of the cDNA library from which the 
LT gene may be cloned and can be used to identify 
such clones by determining whether mRNA which 
they ‘fish out’ can be translated to LT in microin- 
jetted oocytes. Finally, translation of human LT 
mRNA to biologically active molecules, in as large 
a cell as the Xenopus oocyte, may become a useful 
model system for ultrastructural study of syn- 
thesis, intracellular transport and secretion of this 
protein. 
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